Anti-Bcr-abl antibody [7C6] - BSA and Azide free
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Mouse Recombinant Monoclonal BCR antibody. Carrier free. Suitable for ICC/IF, WB and reacts with Human samples.
View Alternative Names
BCR1, D22S11, BCR, Breakpoint cluster region protein, Renal carcinoma antigen NY-REN-26
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Bcr-abl antibody [7C6] - BSA and Azide free (AB256126)
This data was developed using ab187831, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 fixed K562 (human chronic myelogenous leukemia lymphoblast) cells labeling Bcr-abl with ab187831 at 1/250 dilution, followed by ab150113 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) secondary antibody at 1/1000 dilution (Green). Confocal image showing strongly cytoplasmic staining in K-562 cell line. The nuclear counter stain id DAPI (Blue). Tubulin is detected using ab179513 Anti-beta Tubulin rabbit monoclonal antibody at 1/200 dilution, followed by ab150080 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 594) at 1/500 dilution (Red).
The negative controls are as follows :
-ve control 1 : ab187831 at 1/250 dilution, followed by ab150080 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 594) secondary at 1/500 dilution.
-ve control 2 : Primary (ab179513) at 1/200 dilution, followed by ab150113 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) secondary at 1/1000 dilution.
- WB
Lab
Western blot - Anti-Bcr-abl antibody [7C6] - BSA and Azide free (AB256126)
This data was developed using ab187831, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Lysates should be non-boiled as boiling may cause protein aggregates.
Exposure time : 59 seconds
All lanes:
Western blot - Anti-Bcr-abl antibody [7C6] - BSA and Azide free (ab256126) at 1/1000 dilution
Lane 1:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 10 µg
Lane 2:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 10 µg
Lane 3:
HEK-293 (human embryonic kidney epithelial cell), whole cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Mouse IgG, (H+L), Peroxidase conjugated at 1/10000 dilution
Predicted band size: 197 kDa
Observed band size: 142 kDa,210 kDa
false
Related conjugates and formulations (1)
-
Anti-Bcr-abl antibody [7C6]
Reactivity data
Product details
ab256126 is the carrier-free version of ab187831.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Bcr-abl significantly alters normal cell functions by constantly activating signals that drive cell cycle progression and inhibit apoptosis. This protein forms a complex with various signaling molecules enhancing proliferative signals within the cell. The presence of BCR/ABL leads to abnormal interaction with cell cycle regulators and contributes to dysregulated growth characteristic of cancerous cells. Through these interactions Bcr-abl affects DNA repair processes and cytoskeletal remodelling both of which are critical for maintaining genomic stability and cellular integrity.
Pathways
Bcr-abl influences multiple signaling cascades prominently including the PI3K-AKT and RAS-RAF-MEK-ERK pathways. These pathways are pivotal for transmitting growth factor signals that promote cell survival and proliferation. BCR-ABL activates these pathways independently of growth factor binding which leads to uncontrolled proliferation and resistance to apoptosis. Additionally Bcr-abl interacts with proteins such as GRB2 and SHC which are parts of these signaling networks further amplifying growth and survival signals in affected cells.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com